KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cvs Health (CVS) Receivables - Other (2017 - 2025)

Cvs Health's Receivables - Other history spans 9 years, with the latest figure at $10.6 billion for Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Other rose 6.9% year-over-year to $10.6 billion, compared with a TTM value of $10.6 billion through Dec 2025, up 6.9%, and an annual FY2025 reading of $10.6 billion, up 6.9% over the prior year.
  • Receivables - Other for Q4 2025 was $10.6 billion at Cvs Health, down from $11.2 billion in the prior quarter.
  • The five-year high for Receivables - Other was $11.9 billion in Q4 2023, with the low at $7.7 billion in Q1 2021.
  • Average Receivables - Other over 5 years is $9.6 billion, with a median of $9.8 billion recorded in 2024.
  • Year-over-year, Receivables - Other skyrocketed 32.56% in 2023 and then decreased 17.02% in 2024.
  • Tracing CVS's Receivables - Other over 5 years: stood at $7.9 billion in 2021, then rose by 13.25% to $9.0 billion in 2022, then skyrocketed by 32.56% to $11.9 billion in 2023, then decreased by 17.02% to $9.9 billion in 2024, then increased by 6.9% to $10.6 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Receivables - Other are $10.6 billion (Q4 2025), $11.2 billion (Q3 2025), and $10.5 billion (Q2 2025).